Archive for the 'Avastin' Category

Genentech Disappointed With FDA Panel Vote For Revoking Avastin Approval

Roche's cancer drug Avastin, which costs less than Lucentis, also targets VEGF and doctors sometimes use it off- label to treat patients with age-related macular degeneration. Avastin costs $50 per shot, while Lucentis costs about $2000 for each Roche's cancer drug Avastin, which costs less than Lucentis, also targets VEGF and doctors sometimes use it [...]

Race Against the Cure

June 20 (Bloomberg) — Roche Holding AG doesn't need to disclose financial ties to presenters supporting the use of Avastin in breast cancer, said a hearing officer who rejected a petition from US regulators calling for more transparency. Roche set for crucial Avastin hearing. The FDA is due to begin a two-day appeals hearing today [...]

Avastin Pits Breast Cancer Patients Against FDA Experts

By LARA SALAHI (@LaraSalahiABC) The FDA holds hearings to decide the fate of Avastin in the treatment of breast cancer. (Jb Reed/Bloomberg via Getty Images) Priscilla Howard, who has metastatic breast cancer, has been taking the drug Avastin for a The FDA says the world's best-selling cancer drug, Avastin, is ineffective against treating breast cancer. [...]